Lee E. Goldstein

Lee E. Goldstein

Auto-generated profile, based on publicly available information

Lee E. Goldstein

Boston University Chobanian & Avedisian School of Medicine, Boston, MA USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2012 in Brain
Verified
Journal Article
Open access
PDF file
AMAnn C. McKee
Ann C. McKee
TSThor Stein
Thor Stein
CNChristopher J. Nowinski
Christopher J. Nowinski
RSRobert A Stern
Robert A Stern
DDDaniel H. Daneshvar
Daniel H. Daneshvar
RCRobert C. Cantu
Robert C. Cantu
Chronic traumatic encephalopathy is a progressive tauopathy that occurs as a consequence of repetitive mild traumatic brain injury. We analysed post-mortem brains obtained from a cohort of 85 subjects with histories of repetitive mild traumatic brain injury and found evidence of chronic traumatic encephalopathy in 68 subjects: all males, ranging in age from 17 to 98 years (mean 59.5 years), including 64 athletes, 21 military veterans (86% of whom were also athletes) and one individual who engaged in self-injurious head banging behaviour. Eighteen age- and gender-matched individuals without a history of repetitive mild traumatic brain injury served as control subjects. In chronic traumatic encephalopathy, the spectrum of hyperphosphorylated tau pathology ranged in severity from focal perivascular epicentres of neurofibrillary tangles in the frontal neocortex to severe tauopathy affecting widespread brain regions, including the medial temporal lobe, thereby allowing a progressive staging of pathology from stages I–IV. Multifocal axonal varicosities and axonal loss were found in deep cortex and subcortical white matter at all stages of chronic traumatic encephalopathy. TAR DNA-binding protein 43 immunoreactive inclusions and neurites were also found in 85% of cases, ranging from focal pathology in stages I–III to widespread inclusions and neurites in stage IV. Symptoms in stage I chronic traumatic encephalopathy included headache and loss of attention and concentration. Additional symptoms in stage II included depression, explosivity and short-term memory loss. In stage III, executive dysfunction and cognitive impairment were found, and in stage IV, dementia, word-finding difficulty and aggression were characteristic. Data on athletic exposure were available for 34 American football players; the stage of chronic traumatic encephalopathy correlated with increased duration of football play, survival after football and age at death. Chronic traumatic encephalopathy was the sole diagnosis in 43 cases (63%); eight were also diagnosed with motor neuron disease (12%), seven with Alzheimer’s disease (11%), 11 with Lewy body disease (16%) and four with frontotemporal lobar degeneration (6%). There is an ordered and predictable progression of hyperphosphorylated tau abnormalities through the nervous system in chronic traumatic encephalopathy that occurs in conjunction with widespread axonal disruption and loss. The frequent association of chronic traumatic encephalopathy with other neurodegenerative disorders suggests that repetitive brain trauma and hyperphosphorylated tau protein deposition promote the accumulation of other abnormally aggregated proteins including TAR DNA-binding protein 43, amyloid beta protein and alpha-synuclein.

1 May 2001 in Neuron
Verified
Journal Article
Closed access
RCRobert A Cherny
Robert A Cherny
CACraig S Atwood
Craig S Atwood
MXMichel E Xilinas
Michel E Xilinas
DGDanielle N Gray
Danielle N Gray
WJWalton D Jones
Walton D Jones
Ashley I. BushAshley I. Bush
Ashley I. Bush

3 March 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSStephanie J. Soscia
Stephanie J. Soscia
JKJames E. Kirby
James E. Kirby
KWKevin J. Washicosky
Kevin J. Washicosky
STStephanie M. Tucker
Stephanie M. Tucker
MIMartin Ingelsson
Martin Ingelsson
RMRobert D. Moir
Robert D. Moir
The amyloid β-protein (Aβ) is believed to be the key mediator of Alzheimer's disease (AD) pathology. Aβ is most often characterized as an incidental catabolic byproduct that lacks a normal physiological role. However, Aβ has been shown to be a specific ligand for a number of different receptors and other molecules, transported by complex trafficking pathways, modulated in response to a variety of environmental stressors, and able to induce pro-inflammatory activities. Here, we provide data supporting an in vivo function for Aβ as an antimicrobial peptide (AMP). Experiments used established in vitro assays to compare antimicrobial activities of Aβ and LL-37, an archetypical human AMP. Findings reveal that Aβ exerts antimicrobial activity against eight common and clinically relevant microorganisms with a potency equivalent to, and in some cases greater than, LL-37. Furthermore, we show that AD whole brain homogenates have significantly higher antimicrobial activity than aged matched non-AD samples and that AMP action correlates with tissue Aβ levels. Consistent with Aβ-mediated activity, the increased antimicrobial action was ablated by immunodepletion of AD brain homogenates with anti-Aβ antibodies. Our findings suggest Aβ is a hitherto unrecognized AMP that may normally function in the innate immune system. This finding stands in stark contrast to current models of Aβ-mediated pathology and has important implications for ongoing and future AD treatment strategies.

27 May 1999 in Biochemistry
Verified
Journal Article
Closed access
XHXudong Huang
Xudong Huang
CACraig S. Atwood
Craig S. Atwood
MHMariana A. Hartshorn
Mariana A. Hartshorn
GMGerd Multhaup
Gerd Multhaup
LGLee E. Goldstein
Lee E. Goldstein
Ashley I. BushAshley I. Bush
Ashley I. Bush

16 May 2012 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
LGLee E. Goldstein
Lee E. Goldstein
AFAndrew M. Fisher
Andrew M. Fisher
CTChad A. Tagge
Chad A. Tagge
XZXiao-Lei Zhang
Xiao-Lei Zhang
Libor VelisekLibor Velisek
Libor Velisek
AMAnn C. McKee
Ann C. McKee
Blast exposure is associated with chronic traumatic encephalopathy, impaired neuronal function, and persistent cognitive deficits in blast-exposed military veterans and experimental animals.

1 December 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XHXudong Huang
Xudong Huang
Math P. CuajungcoMath P. Cuajungco
Math P. Cuajungco
CACraig S. Atwood
Craig S. Atwood
MHMariana A. Hartshorn
Mariana A. Hartshorn
Joel TyndallJoel Tyndall
Joel Tyndall
Ashley I. BushAshley I. Bush
Ashley I. Bush
Oxidative stress markers as well as high concentrations of copper are found in the vicinity of Aβ amyloid deposits in Alzheimer's disease. The neurotoxicity of Aβ in cell culture has been linked to H2O2generation by an unknown mechanism. We now report that Cu(II) markedly potentiates the neurotoxicity exhibited by Aβ in cell culture. The potentiation of toxicity is greatest for Aβ1–42 > Aβ1–40 ≫ mouse/rat Aβ1–40, corresponding to their relative capacities to reduce Cu(II) to Cu(I), form H2O2 in cell-free assays and to exhibit amyloid pathology. The copper complex of Aβ1–42 has a highly positive formal reduction potential (≈+500–550 mV versus Ag/AgCl) characteristic of strongly reducing cuproproteins. These findings suggest that certain redox active metal ions may be important in exacerbating and perhaps facilitating Aβ-mediated oxidative damage in Alzheimer's disease.